Researchers Develop New Therapy to Target Herpes Simplex-1 Virus
Researchers at the University of Illinois at Chicago (UIC) have identified a small drug molecule that shows promise for treating herpes simplex-1 virus (HSV-1).
A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.
